These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11696459)

  • 1. The time has come to stop letting the HERS tale wag the dogma.
    Mendelsohn ME; Karas RH
    Circulation; 2001 Nov; 104(19):2256-9. PubMed ID: 11696459
    [No Abstract]   [Full Text] [Related]  

  • 2. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
    Groh KW; Stevermer JJ
    J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond the null hypothesis--do the HERS results disprove the estrogen/coronary heart disease hypothesis?
    Blumenthal RS; Zacur HA; Reis SE; Post WS
    Am J Cardiol; 2000 Apr; 85(8):1015-7. PubMed ID: 10760346
    [No Abstract]   [Full Text] [Related]  

  • 4. Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():411-2. PubMed ID: 12449905
    [No Abstract]   [Full Text] [Related]  

  • 5. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution.
    Ylikorkala O
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1029-36. PubMed ID: 11130082
    [No Abstract]   [Full Text] [Related]  

  • 6. [Secondary and tertiary prevention of atherosclerotic vessel disease].
    Husmann F
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):195-8. PubMed ID: 10802893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postmenopausal hormone therapy after WHI and HERS].
    Birkhäuser M; de Geyter C; Keller PJ; Luzuy F
    Gynakol Geburtshilfliche Rundsch; 2004 Oct; 44(4):244-8. PubMed ID: 15459524
    [No Abstract]   [Full Text] [Related]  

  • 8. Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003.
    Simpkins JW; Singh M
    J Womens Health (Larchmt); 2004 Dec; 13(10):1165-8. PubMed ID: 15650349
    [No Abstract]   [Full Text] [Related]  

  • 9. Postmenopausal hormone therapy offers no protection against heart attacks.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():404-5. PubMed ID: 12448045
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammation, coronary artery disease, and hormones.
    Lobo RA
    Menopause; 2008; 15(6):1036-8. PubMed ID: 18779754
    [No Abstract]   [Full Text] [Related]  

  • 11. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Pines A; Sturdee D
    Ann Intern Med; 2010 Jul; 153(1):61; author reply 61-2. PubMed ID: 20621912
    [No Abstract]   [Full Text] [Related]  

  • 12. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Sullivan JL
    Ann Intern Med; 2010 Jul; 153(1):61; author reply 61-2. PubMed ID: 20621911
    [No Abstract]   [Full Text] [Related]  

  • 13. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Harman SM; Brinton EA; Naftolin F; Merriam GR; Cedars MI; Freeman RG; Santoro N
    Ann Intern Med; 2010 Jul; 153(1):60-1; author reply 61-2. PubMed ID: 20621909
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone replacement therapy to prevent coronary events.
    Richard D; Newton WP
    J Fam Pract; 1998 Nov; 47(5):333-4. PubMed ID: 9834761
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's health. The vanishing promises of hormone replacement.
    Enserink M
    Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of estrogen-progestins in secondary prevention].
    Modena MG; Origliani G; Rossi R
    Ital Heart J Suppl; 2000 Mar; 1(3):435-6. PubMed ID: 10815281
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary heart disease in women, randomized clinical trials, HERS and RUTH.
    Barrett-Connor E; Wenger NK; Grady D; Mosca L; Collins P; Kornitzer M; Cox DA; Moscarelli E; Anderson PW
    Maturitas; 1998 Nov; 31(1):1-7. PubMed ID: 10091198
    [No Abstract]   [Full Text] [Related]  

  • 20. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.